202931-70-2

Basic information

• Product Name: 3,6-Dichloro-4-(4-pyridinyl)pyridazine
• Synonyms: 3,6-Dichloro-4-(4-pyridinyl)pyridazine;3,6-Dichloro-4-(pyridin-4...;3,6-dichloro-4-(pyridine-4-yl)pyridazine;3,6-Dichloro-4-(pyridin-4-yl)pyridazine;Pyridazine, 3,6-dichloro-4-(4-pyridinyl)-
• CAS NO: 202931-70-2
• Molecular Formula: C₉H₅Cl₂N₃
• Molecular Weight: 226.06
• EINECS: 200-001-2
• Mol File: 202931-70-2.mol

Chemical Properties

• Boiling Point: 397.6 °C at 760 mmHg
• Flash Point: 226.5 °C
• Appearance: /
• Density: 1.428
• PKA: 1.10±0.10(Predicted)
• CAS DataBase Reference: 3,6-Dichloro-4-(4-pyridinyl)pyridazine(CAS DataBase Reference)
• NIST Chemistry Reference: 3,6-Dichloro-4-(4-pyridinyl)pyridazine(202931-70-2)
• EPA Substance Registry System: 3,6-Dichloro-4-(4-pyridinyl)pyridazine(202931-70-2)

Safety Data

• Hazardous Substances Data: 202931-70-2(Hazardous Substances Data)

Usage

Uses

Used in Research and Synthesis:
3,6-Dichloro-4-(4-pyridinyl)pyridazine is used as a research compound for the development and synthesis of new chemical entities. Its unique structure and properties make it a valuable component in the creation of novel molecules with potential applications in various fields.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 3,6-Dichloro-4-(4-pyridinyl)pyridazine is used as a building block for the synthesis of new drug candidates. Its heterocyclic nature allows for the formation of complex molecules with potential therapeutic effects, making it a valuable asset in drug discovery and development.
Used in Chemical Synthesis:
3,6-Dichloro-4-(4-pyridinyl)pyridazine is used as a reagent in the synthesis of various organic compounds. Its ability to form stable bonds with other molecules makes it a useful intermediate in the production of a wide range of chemical products.

Upstream product

• 1692-15-5 4-pyridylboronic acid 
• 15456-86-7 4-bromo-1,2-dihydropyridazine-3,6-dione 

Downstream Products

• 202931-71-3 6-chloro-3-phenyl-7-(pyridin-4-yl)-1,2,4-triazolo[4,3-b]pyridazine 

Relevant articles and documents

NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

Disclosed by the present invention are a nitrogen-containing heterocyclic compound, and a composition thereof, a preparation method therefor and an application thereof. The structure of the nitrogen-containing heterocyclic compound according to the presen

MAP KINASE MODULATORS AND USES THEREOF

The invention provides for novel MAP kinase inhibitors and compositions comprising the same. In some embodiments, the MAP kinase inhibitors are p38a MAP kinase inhibitors. The invention further provides for methods for treatment of diseases comprising adm

Substituted triazolo-pyridazine derivatives as ligands for GABA receptors

Substituted triazolo-pyridazine derivative compounds represented by wherein the variables are disclosed herein are selective ligands for GABA-A receptors, particularly for the α2 and/or α3 subunits.